Sight Sciences Inc SGHT.OQ SGHT.O is expected to show a rise in quarterly revenue when it reports results on March 4 for the period ending December 31 2025
The Menlo Park California-based company is expected to report a 7.0% increase in revenue to $20.403 million from $19.07 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
LSEG's mean analyst estimate for Sight Sciences Inc is for a loss of 14 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Sight Sciences Inc is $9.05, about 75.4% above its last closing price of $5.16
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2025 | -0.24 | -0.25 | -0.16 | Beat | 36.6 |
Jun. 30 2025 | -0.26 | -0.26 | -0.23 | Beat | 12.7 |
Mar. 31 2025 | -0.27 | -0.28 | -0.28 | Met | 0.8 |
Dec. 31 2024 | -0.21 | -0.20 | -0.23 | Missed | -13 |
Sep. 30 2024 | -0.22 | -0.21 | -0.22 | Missed | -6 |
Jun. 30 2024 | -0.30 | -0.30 | -0.25 | Beat | 15.5 |
Mar. 31 2024 | -0.26 | -0.28 | -0.33 | Missed | -19.7 |
Dec. 31 2023 | -0.30 | -0.32 | -0.22 | Beat | 30.6 |
This summary was machine generated March 2 at 21:25 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)